Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
about
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramStem cell bioprocessing: fundamentals and principlesEthical issues in neonatal and pediatric clinical trials.Hematopoetic stem cell transplantation in childrenAcute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor ProgramHaematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantationDonor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?Allogeneic peripheral blood stem cell collection as of 2008.Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.Hematopoietic stem cell donation in children: a review of the sibling donor experience.Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation.Cord blood stem cell transplantation for haemoglobinopathies.Research involving pediatric stem cell donors: A way forward.Related hematopoietic cell donor care: is there a role for unrelated donor registries?G-CSF-primed BM for allogeneic SCT: revisited.Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors.Procedure-related complications and adverse events associated with pediatric autologous peripheral blood stem cell collection.Factors associated with bone marrow stem cell yield for pediatric allogeneic stem cell transplantation: The impact of donor characteristics.Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors.Parent versus child donor perceptions of the bone marrow donation experience.Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents.Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy?Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.Children as hematopoietic cell donors in research: when is it approvable?Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.Early engraftment of G-CSF-primed allogeneic bone marrow transplantation in pediatric patients regardless of donor-recipient weight differences.Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion.
P2860
Q24642481-AF9F5837-3D98-441E-B7AD-2BB491F51215Q24653942-ADE0537B-EDEF-4845-BAF6-CABE7E5CBBA3Q27693246-8DC5CF83-33B4-4DB3-8605-D6E364D45249Q28088687-6430372D-8BA9-4AF9-A8DD-1AA7F3887D16Q33161966-3D93359D-47E7-40E8-868F-14EC988E3C67Q33373051-6A562F27-1C42-4760-8A91-F098A8E54353Q33585868-27822F60-F106-4186-B66A-724B98F42166Q33819995-CEABE369-3B23-419A-B79E-63F8263A8C25Q34320722-4BDB58FD-E2EC-4E25-836B-57F7E880DE8EQ35154218-98AA1249-2233-4CF5-8CF1-5E76ADA67999Q36180365-3E404B5B-28F4-444C-B145-E8FC29745F6BQ36632341-281D3E0C-6EC4-49D9-8941-6E7C1BB0CE35Q36766486-93440FA9-D8A0-41A5-BB67-933BF9430E51Q37096984-9A02070A-5426-4285-8DF9-5B4003702493Q37136342-F7AB4DCD-8F42-450E-99AF-CBF996CA054FQ38366630-B665A05D-2D80-43FC-B569-DFFADFC258E9Q38366631-8677E290-A642-463D-AD4F-DEA1A7597030Q38517394-0E8256E8-49A1-4656-BD12-89C69FCD3FF1Q38811659-D87A1848-2E70-45B1-850A-E7452523C9E7Q39215659-71EFC77C-FC2B-423C-A6AE-3A17493D59F3Q40397481-F7A04DE4-7556-46AF-B428-11DFA134C25AQ40481341-993443AA-7E99-4546-9890-6D196DA7211EQ40766348-5FACB63A-B41E-43FC-BA39-5183736537B7Q42697596-D345A170-8A2A-4E73-94D4-B06C37563235Q46783667-684B9051-A125-4CAF-8CBA-C5F4EC9476CBQ46832046-43197821-94F1-4099-A5D3-6E25A185D1CFQ47319087-A4C49239-C62D-425B-8227-9DA63D0B77FCQ47344542-DF205211-8C62-43B3-A118-D1CEABC1DB37Q50472715-2A57A3B6-645A-482D-A9FF-B29CC7680C4B
P2860
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@ast
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@en
type
label
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@ast
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@en
prefLabel
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@ast
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@en
P2093
P356
P1476
Weighing the risks of G-CSF ad ...... ric hematopoietic cell donors.
@en
P2093
Arnon Nagler
Michael A Pulsipher
Robert Iannone
Robert M Nelson
P304
P356
10.1002/PBC.20708
P577
2006-04-01T00:00:00Z